Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
Looking ahead, the demand for NSAIDs in ophthalmology from 2023 to 2033 is expected to continue rising. Factors contributing to this include advancements in ophthalmic drug formulations, increased awareness of eye health, and the aging global population, which is more prone to age-related eye conditions. Additionally, the shift toward minimally invasive surgical techniques in ophthalmology has created a greater need for drugs that support quicker recovery times and reduce inflammation without compromising the healing process. The market's expansion is also supported by growing investments in research and development, aiming to improve drug delivery systems and enhance the effectiveness of NSAIDs in treating a broader range of eye diseases.
In particular, the next decade will likely see a rise in the use of combination therapies that pair NSAIDs with other ophthalmic treatments, optimizing the healing process. For instance, pairing NSAIDs with antibiotics can prevent infection post-surgery while controlling inflammation, allowing for more comprehensive management of conditions. Moreover, the increasing adoption of telemedicine and digital health platforms in ophthalmology provides new opportunities for the remote management of eye diseases, further boosting the demand for NSAIDs. As the treatment options expand, the market is poised for robust growth, with a projected compound annual growth rate (CAGR) of over 5% from 2023 to 2033.
Get an In-Depth Research Analysis of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size And Forecast [2025-2032]
The Non-steroidal Anti-inflammatory Drugs (NSAIDs) for Ophthalmology market has witnessed significant growth between 2018 and 2022, driven by the increasing prevalence of ophthalmic diseases and the growing demand for effective treatments. These drugs have become integral in managing eye conditions such as cataract surgery inflammation, conjunctivitis, and postoperative care. Their ability to reduce inflammation without the side effects typically associated with steroids has made them a preferred choice for both patients and healthcare providers. Market data reveals that the global market for NSAIDs in ophthalmology was valued at approximately USD 1.3 billion in 2022, with steady growth recorded throughout this period. The focus has been on developing specialized NSAIDs that cater specifically to the delicate nature of the eye, minimizing adverse effects and improving patient outcomes.
Â
AbbVie
Bausch Health
Bayer
Dossa Pharmaceuticals
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Sun Pharmaceutical Industries
Senju Pharmaceutical
Sichuan Heyi Pharmaceutical
Shandong Haishan Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Cisen Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market
Hospital
Clinic
Other
Based on Types the Market is categorized into Below types that held the largest Non-steroidal Anti-inflammatory Drugs for Ophthalmology market share In 2023.
Pranoprofen Eye Drops
Diclofenac Sodium Eye Drops
Bromfenac Sodium Eye Drops
Other
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Research Analysis
1. Introduction of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Type
6. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Application
7. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/